Additional file 1: of Ambulatory Medical Assistance - After Cancer (AMA-AC): A model for an early trajectory survivorship survey of lymphoma patients treated with anthracycline-based chemotherapy

List of medical complications administered by the general practitioner (GP). (DOCX 32 kb

Baseline characteristics of the two groups of patients.

<p>LVEF (as assessed by echocardiography); ACEi: Angiotensin converting enzyme inhibitors; AT1: Angiotensin II type 1. Values are median (interquartile range).</p

Comparison of the spontaneous baroreflex control of sympathetic activity between TTC and CHF patients.

<p>In this figure we show the comparison of the spontaneous baroreflex control of sympathetic activity of a single TTC patient (on the right) and a single CHF control patient (on the left).</p

Comparison between a Tako Tsubo patient and a heart failure control patient.

<p>In this figure are showed: microneurographic recording, Muscle Sympathetic Nerve Activity (MSNA) values, Systolic and Diastolic Blood Pressure (SBP, DBP) values and spontaneous baroreflex control of sympathetic activity values in one Tako-Tsubo patient (on the left) and one chronic heart failure patient (on the right). The microneurographic recording well show the increased frequency of sympathetic bursts and then sympathetic activity in Tako-Tsubo patient compared to control.</p

Comparison of MSNA activity between Tako Tsubo patients and CHF control patient.

<p>In this figure we show the comparison of mean MSNA activity, expressed in burst/min, between 13 TTC patients (on the left) and 13 acutely decompensated CHF patients (on the right).</p

Individual values of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), MSNA activity and <b>spontaneous baroreflex control of MSNA</b> for the 13 Tako-Tsubo patients.

<p>Individual values of systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), MSNA activity and <b>spontaneous baroreflex control of MSNA</b> for the 13 Tako-Tsubo patients.</p

Baseline values of the two groups of patients.

<p>Values are median (interquartile range).</p

Baseline characteristics of the two groups of patients.

<p>LVEF (as assessed by echocardiography); ACEi: Angiotensin converting enzyme inhibitors; AT1: Angiotensin II type 1. Values are median (interquartile range).</p